The San Francisco-based venture capital firm has recently led or participated in Series B and Series C funds of companies developing therapies in diseases like cancers and NASH.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,